Combination of the MCL1 inhibitor PRT1419 and SMARCA2 degrader PRT3789 shows combinatorial benefit in SMARCA4 deleted lung cancerNorman Fultang,Neha Bhagwat,Diane Heiser,Alexander Grego,Michael Hulse,Venkat Thodima,Koichi Ito,Kris Vaddi,Bruce Ruggeri,Peggy ScherleCANCER RESEARCH(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要